Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0PG7W
|
|||
Drug Name |
US10150740, Example 1
|
|||
Synonyms |
SCHEMBL18425452; US10150740, Example 1; BDBM307505
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H14N2O5
|
|||
Canonical SMILES |
COC1=C(C=C2C(=C1)CNN3C2=CC(=O)C(=C3)C(=O)O)OC
|
|||
InChI |
1S/C15H14N2O5/c1-21-13-3-8-6-16-17-7-10(15(19)20)12(18)5-11(17)9(8)4-14(13)22-2/h3-5,7,16H,6H2,1-2H3,(H,19,20)
|
|||
InChIKey |
BPBHVSAWZGGVPZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Hepatitis C virus Core protein messenger RNA (HCV Core mRNA) | Target Info | Inhibitor | [1] |
Target's Patent Info | Hepatitis C virus Core protein messenger RNA (HCV Core mRNA) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | 6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection. US10150740. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.